Acticor Biotech: Funding, Investors & Team (Sep 2026)
Acticor Biotech is a biopharmaceutical company working on a new medication for acute ischemic stroke. The company's project is driven by the urgent need for more treatment options for stroke, a condition that affects millions of people worldwide each year. Despite the high mortality and disability rates associated with stroke, current treatments are limited in their effectiveness. Acticor Biotech, founded in 2013 and based in Paris, is aiming to address this critical need with their innovative drug development efforts.
Acticor Biotech has raised $21.6M across 2 funding rounds on record, the most recent an undisclosed round of $8.7M announced in Mar 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Acticor Biotech Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Acticor Biotech Funding Rounds
Acticor Biotech raised $12.9M in an undisclosed round announced in Mar 2023.
1 years later, an undisclosed round of $8.7M was announced in Mar 2024.
Acticor Biotech Founders and Leadership Team
Contact details for the Acticor Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Acticor Biotech Funding Compared to Other Biotechnology Startups
Acticor Biotech's latest round of $8.7M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acticor Biotech in Biotechnology and Paris
Companies Similar to Acticor Biotech
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Acticor Biotech Funding FAQs
What does Acticor Biotech do?
Acticor Biotech is a biopharmaceutical company working on a new medication for acute ischemic stroke. The company's project is driven by the urgent need for more treatment options for stroke, a condition that affects millions of people worldwide each year. Despite the high mortality and disability rates associated with stroke, current treatments are limited in their effectiveness. Acticor Biotech, founded in 2013 and based in Paris, is aiming to address this critical need with their innovative drug development efforts.
How much funding has Acticor Biotech raised?
Acticor Biotech has raised $21.6M across 2 rounds on record. The most recent is an undisclosed round of $8.7M announced in Mar 2024.
When did Acticor Biotech last raise funding?
Acticor Biotech's most recent funding round on record is an undisclosed round of $8.7M, announced in Mar 2024.
Who founded Acticor Biotech?
FundedIQ lists Gilles Avenard (Founder) at Acticor Biotech.
Where is Acticor Biotech headquartered?
Acticor Biotech is based in Paris, Ile-De-France, France.
How many employees does Acticor Biotech have?
Acticor Biotech is in the 11-50 employee band.
How does Acticor Biotech's funding compare to other Biotechnology startups?
Acticor Biotech's latest round of $8.7M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Acticor Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acticor Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.